[Expert opinion on APAP (prolonged action atypical antipsychotic agents). Position of the pharmacologist. From neuroleptics to non-neuroleptic antipsychotics].
Costentin
J
J
Faculté de Médecine, CHU de Rouen.
D000284:Administration, Oral; D000818:Animals; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics*; D001291:Attitude of Health Personnel; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D002375:Catalepsy / Q000097:blood / Q000139:chemically induced; D002908:Chronic Disease; D003692:Delayed-Action Preparations; D004305:Dose-Response Relationship, Drug; D004339:Drug Compounding; D004409:Dyskinesia, Drug-Induced / Q000097:blood / Q000517:prevention & control; D006801:Humans; D007273:Injections, Intramuscular; D018377:Neurotransmitter Agents / Q000097:blood; D010595:Pharmacists; D012559:Schizophrenia / Q000097:blood* / Q000188:drug therapy*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D018377:Neurotransmitter Agents